Details of Disease
General Information of Disease (ID: DISUVPQG)
Disease Name | Orotic aciduria | |||||
---|---|---|---|---|---|---|
Synonyms |
orotic aciduria II (formerly); UMP synthtase deficiency; Umps deficiency; OPRT and ODC deficiency; Ump synthase deficiency; UMPS; hereditary orotic aciduria; orotic aciduria without megaloblastic Anemia; orotidylic pyrophosphorylase and orotidylic decarboxylase deficiency; oroticaciduria 1; orotate phosphoribosyltransferase and orotidylic decarboxylase deficiency; orotic aciduria without megaloblastic Anaemia; orotate phosphoribosyltransferase and OMP decarboxylase deficiency; uridine monophosphate synthase deficiency; orotic aciduria 1; orotic aciduria type 1; Hereditary Orotic Aciduria; orotidylic decarboxylase deficiency; orotic aciduria; oroticaciduria; uridine monophosphate synthetase deficiency
|
|||||
Definition |
An extremely rare autosomal recessive inherited disorder caused by mutations in the UMPS gene. It is characterized by deficiency of the activity of the pyrimidine pathway enzyme uridine 5'-monophosphate (UMP) synthase. Clinical manifestations include growth retardation, anemia, and increased excretion of orotic acid in the urine.
|
|||||
Disease Hierarchy | ||||||
Disease Identifiers | ||||||
Drug-Interaction Atlas (DIA) of This Disease
Drug-Interaction Atlas (DIA) | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
This Disease is Treated as An Indication in 1 Approved Drug(s)
|
|||||||||||||||||||||||||
Molecular Interaction Atlas (MIA) of This Disease
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
This Disease Is Related to 1 DOT Molecule(s)
|
|||||||||||||||||||||||||
This Disease Is Related to 1 DTT Molecule(s)
|
|||||||||||||||||||||||||
This Disease Is Related to 1 DME Molecule(s)
|
|||||||||||||||||||||||||